Противоопухолевые препараты: литература
Veterinary Cancer Society Proceeding of Annual Conferences. The best overview of recent developments in veterinary oncology, containing abstracts relating to current clinical trials often a year or more before publication in journals. To receive VCS newsletters and proceedings contact Dr. Richard E. Weller, Treasurer, Veterinary Cancer Society, Developmental Toxicobgy Section, Batelle, Pacific Northwest Labs, P.O. Box 999, Mail Stop K810, Richland, WA 99352.
Ogilvie GK, Moore AS: Managing the Veterinary Cancer Patient. Trenton, NJ: Veterinary Learning Systems, 1995. A user-friendly practice manual and thorough, up-to-date review of the literature relating to veterinary oncology.
Knapp DW, Richardson RC, Bottoms GD, et al: Phase I trial of piroxicam in 62 dogs bearing naturally occurring tumors. Cancer Chemother Pharmacol 29:214, 1992. The largest published study to date of piroxicam therapy in veterinary patients.
Kyles AE, Papich M, Hardie EM: Disposition of transdermally administered fentanyl in dogs. Am J Vet Res 57:715,1996. A pharmacokinetic study of the fentanyl patch in normal dogs.
MacEwen EG, Kurzman ID: Canine osteosarcoma: Amputation and chemoimmunotherapy. Vet Clin North Am Small Anim Pract 26:123, 1996. Although specifically about osteosarcoma, this is the most recent veterinary publication by the group of researchers who have been studying L-MTP-PE in animals and have published their findings extensively in the veterinary and human medical literature.
Moore AS, Kirk C, Cardona A: Intracavitary cisplatin chemotherapy experience with six dogs. J Vet Intern Med 5:227,1991. The original description of the use of intracavitary chemotherapy in veterinary medicine.
